Australia

2 compound entries are recorded for this jurisdiction. A compound absent from this page has no verified entry here, which means the position has not been established from a primary source — not that no position exists.

Retatrutide
Investigational — no marketing authorisation · TGA
Not included in the Australian Register of Therapeutic Goods. The Therapeutic Goods Administration names retatrutide among unapproved peptide products and states that such goods have not been included in the Register.
- TGA states that research-use-only disclaimers do not make supply lawful or permit importation
Understanding your responsibilities when importing, compounding and supplying unapproved peptide products · verified 2026-07-30
NAD+
No established classification · TGA
The Therapeutic Goods Administration states that NAD, NAD+ and NADH are not permitted ingredients in listed medicines in Australia, that products making therapeutic claims without an ARTG number may be unapproved or illegally supplied, and that compounded medicines are not evaluated for safety, quality or efficacy. A compliance review resulted in nine ARTG cancellations and two recalls.
- NAD, NAD+ and NADH are not permitted ingredients in listed medicines
- Compounded preparations are not evaluated by the regulator for safety, quality or efficacy
NAD, NAD+, NADH or NMN medicines sold in Australia — safety alert · verified 2026-07-30

Scope of this reference

This knowledge base is scientific and regulatory reference material for businesses. It is not medical advice, not a recommendation, and not product promotion. Regulatory classification differs by jurisdiction, by form and by route of administration, and a statement recorded for one territory does not describe the position in another.

HelixEVO does not supply medicinal products for human administration. Material is supplied to businesses for research and manufacturing purposes only. Where a compound holds no marketing authorisation, human administration outside an authorised clinical trial is not a lawful supply route.

Every regulatory and analytical statement carries its source and the date it was last verified. Where a value could not be established from a primary source it is recorded as unverified rather than estimated.

Australia

Retatrutide

NAD+